echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: lifetime risk of interstitial lung disease associated with rheumatoid arthritis in MUC5B mutation carriers

    ARD: lifetime risk of interstitial lung disease associated with rheumatoid arthritis in MUC5B mutation carriers

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Purpose: Interstitial lung disease (ILD) is one of the most common extra-articular complications of rheumatoid arthritis ( RA )
    .


    The MUC5B promoter variant rs35705950 is an important risk factor for inherited ILD .


    Objective: interstitial lung disease (ILD) is one of the most common rheumatoid arthritis ( rheumatoid arthritis RA outer) articular complications


    Methods: FinnGen is a collection of epidemiological cohorts and hospital biobank samples, combining genetic data with 50 years of follow-up by the


    Results: 293 972 individuals were in 1965 Ming (0.
    7%) in 80 developing at the age of ILD


    Conclusion: The results of this study provide lifetime risk estimates of RA-ILD based on the status of MUC5B MUC5B mutation carriers , and demonstrate the potential of genomics for RA-ILD risk stratification .
    Further research is needed to investigate the effect of MUC5B and MUC5B on RA-ILD results .

    Source:

    Source:

    Palomäki A, et al.


    Ann Rheum Dis 2021;80:1530–1536.
    doi:10.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.